OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Nephrology and Hypertension is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes	29
Tackling the intersectoral challenges in kidney diseases and transplantation: shared decision and realistic care for advanced diagnostic and therapeutic modalities for kidney diseases and transplantat	28
Editorial introductions	27
Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction	27
Barriers to home dialysis and kidney transplantation for socially disadvantaged individuals	22
The coronavirus disease 2019 pandemic: the disruptor that maintenance dialysis never anticipated	21
Maximizing opportunities for kidney transplantation in older adults	21
Dual organ transplantation: Pancreas and Liver in the kidney axis	20
Effect of the allelic background on the phenotype of primary hyperoxaluria type I	18
Does cooled dialysate still have a role in reducing intradialytic stress? Implications of the MyTEMP trial	18
Medical nutrition therapy using plant-focused low-protein meal plans for management of chronic kidney disease in diabetes	18
The clinical application of frailty in nephrology and transplantation	18
Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?	17
Interferon gamma in the pathogenesis of hypertension − recent insights	17
Renal denervation for the treatment of hypertension and kidney disease	17
Modern indications for referral for kidney and pancreas transplantation	14
Prediction models for earlier stages of chronic kidney disease	14
International equity in access to home dialysis	14
Reconciling Systolic Blood Pressure Intervention Trial with Eighth Joint National Commission: a nuanced view of optimal hypertension control in the chronic kidney disease population	13
Editorial introduction	13
Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD	12
Recent advances in peritoneal dialysis catheter placement: the association between method of insertion, operator, and prior abdominal surgery and outcomes	12
Editorial: The evolution of my personal conflict of interest: I am part of an ‘ineligible company’	12
Synergistic susceptibility to environmental lead toxicity in chronic kidney disease	12
Bringing the end-stage kidney disease life plan home	12

Staying home when peritoneal dialysis ends: the integrated home dialysis approach	12
The race coefficient in glomerular filtration rate-estimating equations and its removal	11
Plant-based diets for kidney disease prevention and treatment	11
Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease	11
Sodium-glucose cotransporter 2 inhibition in non-diabetic kidney disease	10
Built environment and chronic kidney disease: current state and future directions	10
Sodium phosphate cotransporter 2a inhibitors: potential therapeutic uses	10
Dialysis initiation for patients with decompensated cirrhosis when liver transplant is unlikely	10
Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression	10
Complement detection in kidney biopsies – utility and challenges	10
Editorial introductions	9
Dietary protein intake and plant-dominant diets to mitigate risk of allograft dysfunction progression in kidney transplant recipients	9
Understanding renal phosphate handling: unfinished business	9
Advances in management of hepatorenal syndrome	9
Combination therapy with kidney protective therapies: optimizing the benefits?	9
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future	9
Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension	9
A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?	9
Editorial: Advancements in the management of kidney disease and electrolyte derangements	8
Recent updates in kidney risk prediction modeling: novel approaches and earlier outcomes	8
Noninvasive continuous intradialytic blood pressure monitoring: the key to improving haemodynamic stability	8
Climate change and kidney stones	8
Deep learning applications for kidney histology analysis	8
Lipocalin-2: a novel link between the injured kidney and the bone	8
Kidney dysfunction requiring dialysis is a heterogeneous syndrome: we should treat it like one	8
Cancer drugs and acute kidney injury: new therapies and new challenges	8
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond	7
Emerging non-pharmacological interventions in ADPKD: an update on dietary advices for clinical practice	7
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease	7
HIV-associated kidney disease: the changing spectrum and treatment priorities	7
Impact of intensive blood pressure control on kidney outcomes	7
Editorial: Innovations in multimodal and integrated approaches in kidney care and renal transplantation	7
Recent advances in dialysis membranes	7
The current therapeutic approach for anaemia after kidney transplant	7
Automation and innovation in home hemodialysis machines	7
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism	7
New insights into renal calcium-sensing receptor activation	7
Vaccination in kidney disease: what did we learn from COVID-19 pandemic	6
Renal denervation: recent developments in clinical and preclinical research	6
Treatment options for managing obesity in chronic kidney disease	6
Editorial introduction	6
Sex differences in renal electrolyte transport	6
New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease	6
Contemporary risk prediction models in chronic kidney disease: when less is more	6
Renal osteodystrophy: something old, something new, something needed	6
Editorial introductions	6
Hypernatremia in the intensive care unit	6
New and old approaches to nutritional management of acute and chronic glomerulonephritis	6
Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays	6
Screening for chronic kidney disease: change of perspective and novel developments	6

Epithelial Na+ channel and the glycocalyx: a sweet and salty relationship for arterial shear stress sensing	6
Evolving thresholds for the diagnosis of acute T cell mediated rejection	6
Prospects for gene therapy in polycystic kidney disease	6
Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era	5
Evolving indications and management patterns in heart – kidney transplantation	5
Editorial introductions	5
Frailty, multimorbidity and sarcopaenia in haemodialysis patients	5
Novel intestinal dialysis interventions and microbiome modulation to control uremia	5
Novel approaches in antihypertensive pharmacotherapeutics	5
Building kidney organoids from pluripotent stem cells	5
The genetics of cystinuria – an update and critical reevaluation	5
Proximal tubule responses to injury: interrogation by single-cell transcriptomics	5
Adverse effects during treatment with renin–angiotensin–aldosterone system inhibitors; should we stay or should we stop?	5
New therapeutics for primary hyperoxaluria type 1	5
Targeting inflammation in hypertension	5
The changing trajectory of diabetic kidney disease	5
Multimodal approaches for inequality in kidney care: turning social determinants of health into opportunities	5
New guidelines and therapeutic updates for the management of lupus nephritis	5
Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis	5
The « race » correction in estimating glomerular filtration rate: an European point of view	5
Editorial: A humble way forward amid hype and hope	5